Skip to main content
Back to RA Capital Management

RA Capital Management's Medical Portfolio

Browse 103 Medical companies funded by RA Capital Management. See funding amounts, founder contacts, and investment details.

Medical Companies
103
Total Funding in Medical
$13.9B

Medical Portfolio Companies (103)

Export
BiopharmaHealth CareMedicalPharmaceutical

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

San Diego, United States
September 2025
$100.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyClinical TrialsMedical

PepGen is empowering nucleic acid therapeutics to go the distance.

Oxford, United Kingdom
September 2025
$115.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedical DeviceTherapeutics

Spero Therapeutics develops therapeutics for treatment of gram-negative infections.

Cambridge, United States
September 2022
$9.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical Device

Ceribell focuses on making electroencephalography accessible, efficient, and cost-effective.

Mountain View, United States
September 2022
$50.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.

Grove City, United States
September 2022
$90.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.

San Diego, United States
August 2025
$60.1M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Health CareMedicalMedical DeviceWearables

Empatica is an affective computing company focused on human data analytics.

Cambridge, United States
August 2022
$25.9M
Series B

Founder Contacts

30,000+ verified contacts

MedicalPharmaceuticalTherapeutics

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Dublin, Ireland
August 2025
$2.2M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Boston, United States
July 2023
$60.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceuticalTherapeutics

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Del Mar, United States
July 2024
$30.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyInformation TechnologyMedicalSoftware

Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.

San Francisco, United States
July 2023
$150.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Cambridge, United States
June 2026
$600.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Radnor, United States
June 2026
$500.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BioinformaticsBiotechnologyHealth CareMedical

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Cambridge, United States
June 2022
$1.3B
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Cambridge, United States
June 2023
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeuticsWellness

Medicenna is a clinical stage, privately held, immuno-oncology company.

Toronto, Canada
June 2026
$4.4M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaMedicalTherapeutics

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

Austin, United States
June 2026
$330.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalMen's

Contraline is a clinical-stage biotechnology company that develops male contraceptive solutions.

Charlottesville, United States
June 2026
$92.5M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedicalTherapeutics

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

Victoria, Canada
June 2026
$3.1M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedical

Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.

Chester, United Kingdom
June 2026
$93.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Cambridge, United States
June 2026
$200.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Cambridge, United States
June 2026
$50.0M
Grant

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalPharmaceuticalPrecision Medicine

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Cambridge, United States
June 2026
$75.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyGeneticsMedical

SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.

South San Francisco, United States
June 2026
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

Basel, Switzerland
May 2026
$165.0M
Series B

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Health CareMedicalMedical Device

Exo is a medical device startup which develops handheld ultrasound devices and AI for imaging and therapeutic applications.

Redwood City, United States
May 2025
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Dallas, United States
May 2026
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Cambridge, United States
May 2026
$55.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

San Francisco, United States
May 2026
$1.3B
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

Cambridge, United States
May 2024
$120.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedicalWellness

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

Cambridge, United States
April 2026
$100.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalNeurosciencePharmaceutical

Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.

Redmond, United States
April 2026
$110.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.

Foster City, United States
April 2026
$5.0M
Convertible Note

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.

Copenhagen, Denmark
April 2026
$75.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedical

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Charlestown, United States
March 2026
$240.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareMedicalPharmaceuticalTherapeutics

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

Natick, United States
March 2024
$182.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Terrestrial Bio engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
March 2026
$50.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Pinnacle Medicines is a peptide drug discovery company that provides peptide modality for medical needs.

Doylestown, United States
March 2026
$89.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.

San Diego, United States
March 2024
$175.0M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

Bothell, United States
March 2025
$110.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareHealth DiagnosticsMedical

Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.

Los Altos, United States
March 2024
$50.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Westlake Village, United States
February 2026
$130.0M
Series D

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedical

Zura Bio is a clinical-stage, multi-asset biotechnology company.

Henderson, United States
February 2026
$144.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareHealth DiagnosticsHospitalMedicalPrimary and Urgent CareWellness

Somatus is a healthcare company that partners with health plans, health systems, nephrology, and primary care groups.

Mclean, United States
February 2022
$325.0M
Series E

Founder Contacts

30,000+ verified contacts

Health CareMedicalMedical DeviceRobotics

MMI is focused on advancing robotic technology for soft tissue open surgery with the world's smallest wristed instruments.

Pisa, Italy
February 2024
$110.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

Waltham, United States
February 2023
$15.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.

New York, United States
February 2026
$400.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncologyTherapeutics

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

Redwood City, United States
February 2026
$50.1M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Abcuro develops immunotherapies to treat autoimmunity and cancer.

Newton, United States
February 2025
$200.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalPharmaceutical

Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.

Copenhagen, Denmark
October 2025
$157.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalMedical DeviceTherapeutics

VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.

Boulder, United States
October 2025
$17.3M
Series B

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical

Indapta Therapeutics is a privately held biotechnology company.

San Francisco, United States
October 2025
$50.8M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeutics

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

South San Francisco, United States
September 2025
$125.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.

London, United Kingdom
September 2025
$32.0M
Series A

Founder Contacts

30,000+ verified contacts

DeliveryMedicalPharmaceutical

Spyglass Pharma provides medicine for ophthalmic diseases.

Aliso Viejo, United States
June 2025
$75.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

Cambridge, United States
April 2025
$9.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

San Mateo, United States
March 2025
$35.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedical

Bambusa Therapeutics operates as biotechnology company.

Boston, United States
February 2025
$90.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalProduct Research

AmbAgon Therapeutics is a developer of cancer molecule therapeutics.

San Francisco, United States
February 2025
$5.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

Health CareMedicalNeuroscienceWellness

We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US

Chicago, United States
November 2024
$25.0M
Series A

Founder Contacts

30,000+ verified contacts

Clinical TrialsHealth CareMedical Device

Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technology

Ness Ziona, Israel
October 2024
$28.5M
Series B

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Cambridge, United States
September 2024
$40.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.

Boston, United States
September 2024
$120.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalTherapeutics

Halda Therapeutics is a research-stage drug discovery company.

New Haven, United States
August 2024
$126.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Allschwil, Switzerland
June 2024
$90.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

Cambridge, United States
May 2024
$95.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedicalTherapeutics

Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases.

La Jolla, United States
October 2023
$85.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalWellness

Ventricle Health offers evidence-based therapy, remote patient monitoring, patient education, and advocacy services for cardiac care.

Greensboro, United States
October 2023
$8.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Capacity Bio is a therapeutics company that is focused on mitophagy.

Palo Alto, United States
March 2023
$35.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.

London, United Kingdom
January 2025
$411.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyLife ScienceMedicalTherapeutics

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Watertown, United States
January 2026
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.

Menlo Park, United States
January 2023
$100.0M
Series C

Founder Contacts

30,000+ verified contacts

GeneticsHealth CareMedical

Sidera Bio harness human genetics, that helps in transformative medicines for patients.

Copenhagen, Denmark
December 2025
$109.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalTherapeutics

Ambros Therapeutics is a clinical-stage biotechnology company.

Irvine, United States
December 2025
$125.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical Device

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

San Jose, United States
December 2021
$30.0M
Series A

Founder Contacts

30,000+ verified contacts

Health CareMedicalWellness

Tasso is a Medical innovation company changing the way diagnostics are delivered

Seattle, United States
December 2021
$100.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsMedicalTherapeutics

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

South San Francisco, United States
December 2021
$300.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.

Boston, United States
December 2021
$75.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.

Charlottesville, United States
January 2025
$57.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyInformation TechnologyMedicalProduct Research

Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.

Berkeley, United States
November 2025
$65.0M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyMedical Device

Artios Pharma is a biopharmaceutical company that provides new solutions in the DNA damage response (DDR) field.

Cambridge, United Kingdom
November 2025
$115.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

Boston, United States
November 2022
$107.0M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaHealth CareMedicalPharmaceutical

Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.

New York, United States
November 2024
$215.0M
Series B

Founder Contacts

30,000+ verified contacts

Health CareMedicalTherapeutics

Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.

Boston, United States
January 2026
$103.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalProduct Research

Alpha-9 Oncology is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

Vancouver, Canada
October 2024
$175.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Electra Therapeutics is a clinical-stage biotechnology company developing antibody therapies for immunological diseases and cancer.

San Francisco, United States
October 2025
$183.0M
Series C

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalMedical Device

Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.

San Francisco, United States
October 2022
$345.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth DiagnosticsMedicalTherapeutics

C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.

Cambridge, United States
October 2025
$125.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

Health CareMedicalPharmaceutical

Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.

Laguna Hills, United States
October 2025
$19.0M
Post-IPO Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalTherapeutics

Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.

Raleigh, United States
February 2026
$130.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.

Shanghai, China
January 2026
$287.0M
Series D

Founder Contacts

30,000+ verified contacts

Health CareMedicalMedical Device

Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.

Kadima, Israel
July 2024
$105.0M
Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

Suzhou, China
August 2023
$100.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.

Redwood City, United States
June 2021
$15.0M
Post Ipo Equity

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedicalOncology

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Wilmington, United States
May 2021
$200.0M
Series C

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyMedical

New Equilibrium Biosciences provides a platform that reveals opportunities for structure-based design by learning biophysics with AI.

Cambridge, United States
March 2021
$10.0M
Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.

Solana Beach, United States
January 2021
$125.0M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Kira Pharmaceuticals is a Biotechnology Research Company.

Hong Kong, Hong Kong
January 2021
$53.5M
Series B

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.

Boston, United States
August 2020
$72.6M
Series A

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareMedical Device

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Redwood City, United States
August 2020
$70.0M
Series D

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical DeviceOncologyPharmaceuticalTherapeutics

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Dallas, United States
February 2019
$150.0M
Series E

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareMedical

Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.

Arlington, United States
January 2019
$44.0M
Series C

Founder Contacts

30,000+ verified contacts

Health CareMedical DevicePharmaceutical

We transform the management of OUD to help people begin and sustain recovery.

Plymouth Meeting, United States
January 2018
$110.0M
Debt Financing

Founder Contacts

30,000+ verified contacts

Explore RA Capital Management's Full Portfolio

View all companies funded by RA Capital Management across every industry and funding stage.

View Full RA Capital Management Portfolio